William H Rastetter's Net Worth

$135 Million

Estimate Recalculated Jul 9, 2024 06:29PM EST

Who is William H Rastetter?

William H Rastetter has an estimated net worth of $135 Million. This is based on reported shares across multiple companies, which include NEUROCRINE BIOSCIENCES INC, Receptos, Inc., FATE THERAPEUTICS INC, Dare Bioscience, Inc., Regulus Therapeutics Inc., BIOGEN IDEC INC, and ILLUMINA INC.

SEC CIK

William H Rastetter's CIK is 0001205903

Past Insider Trading and Trends

2013 was William H Rastetter's most active year for acquiring shares with 21 total transactions. William H Rastetter's most active month to acquire stocks was the month of April. 2004 was William H Rastetter's most active year for disposing of shares, totalling 20 transactions. William H Rastetter's most active month to dispose stocks was the month of April. 2013 saw William H Rastetter paying a total of $16,723,903.48 for 2,441,572 shares, this is the most they've acquired in one year. In 2013 William H Rastetter cashed out on 14,956,428 shares for a total of $22,306,321.45, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

NEUROCRINE BIOSCIENCES INC (NBIX) Snapshot price: $137.03

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 22
Form 4
+20.93%
8.96K
$72.22
-$1,192,327.07
51.74K
Scheduled
Jan 2
Form 4
—
0
—
—
0
May 17
Form 4
+8.43%
3.33K
$57.07
-$339,221.49
42.78K
May 1
Form 4
+15.98%
5.44K
$58.87
-$571,318.98
39.46K
Apr 19 - Apr 21
Form 4
—
0
—
—
0
May 18
Form 4
+37.46%
9.27K
$50.80
-$885,166.13
34.02K
Scheduled
Apr 1
Form 4
—
0
—
—
0
May 19
Form 4
—
0
—
—
0
May 19
Form 4
—
0
—
—
0
May 22
Form 4
—
0
—
—
0
May 24
Form 4
+73.68%
10.5K
$48.53
-$714,000.00
24.75K
Scheduled
Jan 24
Form 4
—
0
—
—
0
May 22
Form 4
∞
14.25K
$22.23
-$400,260.00
14.25K
Scheduled
Feb 1
Form 4/A
—
0
—
—
0
May 28
Form 4
—
0
—
—
0
May 20
Form 4
—
0
—
—
0
May 28
Form 4
—
0
—
—
0
May 22
Form 4
—
0
—
—
0
May 23
Form 4
—
0
—
—
0
May 23
Form 4
—
0
—
—
0
May 25
Form 4
—
0
—
—
0
Feb 4
Form 3
—
0
—
—
0
No matching records found

Receptos, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-339.63K
—
—
0
Aug 25 - Aug 27
Form 4
∞
7.4K
—
—
7.4K
May 28
Form 4
—
0
—
—
0
Jun 3
Form 4
-2.86%
-37.36K
$30.85
-$1,152,525.15
1.27M
Jan 3
Form 4
-2.07%
-27.58K
$30.29
-$835,428.49
1.31M
Jan 2
Form 4
-27.28%
-500.00K
$27.63
-$13,815,000.00
1.33M
Dec 5
Form 4
-12.00%
-250.00K
$22.05
-$5,512,500.00
1.83M
Nov 21
Form 4
—
0
—
—
0
Jul 17
Form 4
+1,141.29%
2.22M
$9.10
$16,138,405.48
2.41M
May 14
Form 3
—
0
—
—
0
No matching records found

FATE THERAPEUTICS INC (FATE) Snapshot price: $5.65

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 7
Form 4
—
0
—
—
0
Jun 6
Form 4
+322.64%
8.65K
—
—
11.33K
Jun 9
Form 4
∞
2.68K
—
—
2.68K
Jun 2
Form 4/A
—
0
—
—
146.82K
Mar 30
Form 4
—
0
—
—
0
May 1
Form 4
∞
28.46K
$1.37
$38,991.57
28.46K
Mar 30
Form 4
—
0
—
—
0
May 3
Form 4
—
0
—
—
0
May 2
Form 4
—
0
—
—
0
May 2
Form 4
+451.13%
375.94K
$2.66
$999,997.74
459.27K
Nov 23
Form 4
—
0
—
—
0
May 11
Form 4
—
0
—
—
0
May 13
Form 4
—
0
—
—
0
Jun 6
Form 4
∞
83.33K
$6.00
$499,998.00
83.33K
Oct 4
Form 3
—
0
—
—
0
No matching records found

Dare Bioscience, Inc. (DARE) Snapshot price: $0.3301

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 5
Form 4
—
0
—
—
0
Jun 21
Form 4
—
0
—
—
0
Jun 23
Form 4
—
0
—
—
0
Jun 24
Form 4
—
0
—
—
0
Jun 25
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Jul 10
Form 4/A
—
0
—
—
0
Jul 19
Form 4
—
0
—
—
0
Jul 19
Form 4
+30.94%
24.35K
$0.77
$18,749.50
103.04K
Jan 3
Form 4
+30.48%
18.38K
$1.02
$18,749.64
78.69K
Oct 3
Form 4
—
0
—
—
0
Jun 22
Form 4
—
0
—
—
0
Jun 26
Form 4
+145.54%
60.31K
$7.00
$132,083.00
101.75K
Apr 15
Form 3
—
0
—
—
0
No matching records found

Regulus Therapeutics Inc. (RGLS) Snapshot price: $1.37

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 20
Form 4
—
0
—
—
0
May 16
Form 4
—
0
—
—
0
Aug 10
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
Jun 17
Form 4
+137.23%
225.94K
—
—
390.58K
Feb 3
Form 4
—
0
—
—
0
Dec 24
Form 4
—
0
—
—
0
Oct 10
Form 4/A
+151.45%
92.89K
$1.08
$100,320.12
154.22K
May 7
Form 4
+151.45%
92.89K
$1.08
$100,320.12
154.22K
May 7
Form 4
+41.23%
23.26K
—
—
79.67K
Nov 12
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
May 17
Form 4
+11.15%
69.66K
$0.89
$61,999.18
694.39K
Dec 4
Form 4
+78.52%
274.73K
$0.91
$249,999.75
624.63K
Jul 25
Form 4
—
0
—
—
0
Jun 1
Form 4
+250.00%
250K
$1.15
$287,500.00
350K
Mar 7
Form 4
—
0
—
—
0
Jun 2
Form 4
∞
100K
$10.17
$1,016,977.58
100K
Jul 20 - Jul 21
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
May 22
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
Apr 1
Form 3
—
0
—
—
0
No matching records found